apolipoprotein A-IV-targeting therapy (Apofore)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug Nameapolipoprotein A-IV-targeting therapy (Apofore)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoproteins modulators
TargetsApolipoproteins
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cincinnati
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApofore Corp
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A